Clinical Trial Update: Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies [Phase 2]

View source ↗

Summary

Phase 2 dosimetry/validation study of 131Iodine-Anti B1 (murine) radioimmunotherapy in chemotherapy-refractory low-grade B-cell lymphomas, including cases trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Low-grade B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• 131Iodine-Anti B1 (Murine) Radioimmunotherapy

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2012-04-17